Naomi Birbach
Amgen Moves to Dismiss and to Stay Regeneron’s Antitrust Case
Big Molecule Watch ·
FDA Issues Revised Guidance on Biosimilar Development and BPCIA
Big Molecule Watch ·
FDA Releases Biosimilar User Fee Act Rates for Fiscal Year 2022
Big Molecule Watch ·
Genentech and Centus Settle Bevacizumab Litigation
Big Molecule Watch ·
Genentech and Centus Notify Court of Settlement of Bevacizumab Litigation
Big Molecule Watch ·